2009
DOI: 10.1136/bmj.b2606
|View full text |Cite
|
Sign up to set email alerts
|

Access to antimalarial therapy: accurate diagnosis is essential to achieving long term goals

Abstract: Increased attention to and funding for malaria promises to improve access to effective treatment, but Heidi Hopkins, Caroline Asiimwe, and David Bell argue that without diagnostic testing much of this effort will be wasted

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
34
1

Year Published

2011
2011
2019
2019

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 37 publications
(35 citation statements)
references
References 23 publications
0
34
1
Order By: Relevance
“…1 As a result, mRDTs are now being integrated into community case management programmes [2][3][4] to mitigate against parasite resistance to antimalarial drugs and reduce waste associated with presumptive treatment. 5 However, although mRDTs are highly sensitive, 6 health workers still treat for malaria even after negative mRDT test results. 7,8 The fear that a child who has a false negative mRDT result may be sent home to deteriorate has been suggested as the reason why negative mRDT results are so often disregarded.…”
Section: Introductionmentioning
confidence: 99%
“…1 As a result, mRDTs are now being integrated into community case management programmes [2][3][4] to mitigate against parasite resistance to antimalarial drugs and reduce waste associated with presumptive treatment. 5 However, although mRDTs are highly sensitive, 6 health workers still treat for malaria even after negative mRDT test results. 7,8 The fear that a child who has a false negative mRDT result may be sent home to deteriorate has been suggested as the reason why negative mRDT results are so often disregarded.…”
Section: Introductionmentioning
confidence: 99%
“…Timely testing and engagement into care among those infected with human immunodeficiency virus (HIV), tuberculosis (TB), and malaria and infection remains a large public health challenge in sub-Saharan Africa[1]–[3]. Testing is essential to starting the cascade of medical and behavioural interventions designed to improve a patient’s health and reduce their infectiousness [4]–[7].…”
Section: Introductionmentioning
confidence: 99%
“…Up to 90% of all malaria deaths occurred in Africa [1]. Parasite-based malaria diagnosis (PMD) has been shown to improve quality of care, reduce drug consumption [2] and enable early treatment of non-malaria febrile illness [3,4]. In 2009, 33 of 43 malaria-endemic countries in the African region reported having adopted a policy of providing parasitological diagnosis for all age groups [1] including scale up of rapid diagnostic tests (RDTs) at lower level health facilities (LLHF) where microscopy is not feasible.…”
Section: Introductionmentioning
confidence: 99%